Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. G1 Therapeutics Inc’s current trading price is -37.60% away from its 52-week high, while its distance from the 52-week low is 188.89%. The stock’s price range during this period has varied between $1.08 and $5.00. The company, active in the Healthcare sector, saw a trading volume of around 0.55 million for the day, considerably lower average daily volume of 1.54 million observed over the last three months.
The stock market performance of G1 Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $5.00 on 02/08/24, while the lowest price during the same time frame was $1.08, recorded on 10/09/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
G1 Therapeutics Inc (GTHX) has experienced a quarterly decline of -16.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 162.86M and boasts a workforce of 100 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.76, with a change in price of +1.62. Similarly, G1 Therapeutics Inc recorded 1,469,528 in trading volume during the last 100 days, posting a change of +108.00%.
How GTHX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for GTHX stands at 1.62. Similarly, the long-term debt-to-equity ratio is also 1.58.
GTHX Stock Stochastic Average
As of today, the raw stochastic average of G1 Therapeutics Inc over the past 50 days is 37.12%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 58.79%. Additionally, the Stochastic %K and %D values for the company were 68.90% and 65.69%, respectively, over the past 20 days.
GTHX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 2.30% this year. Over the last six months, there has been a weaker performance of 96.23%. The price of GTHX fallen by 48.57% during the last 30 days period. For the last 5-days stocks have slided -12.85%.
